I'm always excited for new data on new treatments and old treatments. Anytime we get really excited about a new potential molecule that we see phase 1 and phase 2 data for, we need that big phase 3 ...
Accenture (NYSE:ACN) held its third-quarter earnings conference call on Thursday. Below is the complete transcript from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results